Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma 
expression

Lodygin, D.; Diebold, J.; Hermeking, H.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression

MPS-Authors

/persons/resource/persons78329

Lodygin, D.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78098

Hermeking, H.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Lodygin, D., Diebold, J., & Hermeking, H. (2004). Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression. Oncogene, 23(56), 9034-9041.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-67F7-9

Abstract

There is no abstract available